Environmental groups said Bayer wants to keep juries out of the lawsuits because it keeps losing in state courts. “It’s a sad day in America when our highest court agrees to consider depriving thousands of Roundup users suffering from cancer of their day in court,” said Lori Ann Burd, environmental health director at the Center for Biological Diversity.
Bayer acquired Roundup as part of its $63 billion purchase of agrochemical company Monsanto in 2018.
Corporate conductAllegationAgainst
A California jury instructed Bayer to pay $2 billion in damages
In the largest payout, in May 2019, a California jury instructed Bayer to pay $2 billion in damages, later cut to $87 million on appeal, to a local couple on the grounds that the company had failed to adequately advise consumers of Roundup’s possible carcinogenic risks.
In the largest payout, in May 2019, a California jury instructed Bayer to pay $2 billion in damages, later cut to $87 million on appeal, to a local couple on the grounds that the company had failed to adequately advise consumers of Roundup’s possible carcinogenic risks.
Corporate conductConfirmedAgainst
Bayer withholds emergency information from agencies
Bayer withheld information from county emergency response agencies during a fire incident.
“The Bayer fire brigade was at the scene in minutes, but Bayer management withheld information from the county emergency response agencies that were desperate for information about what happened, what chemicals were possibly involved,” Mr. Bresland said.
Corporate conductConfirmedAgainst
Bayer pays $100 million for school chemical injuries
Bayer AG was told by a jury to pay $100 million to four people at a Seattle-area school who said their exposure to toxic chemicals made by the company’s Monsanto unit caused brain damage and other injuries.
Bayer AG was told by a jury to pay $100 million to four people at a Seattle-area school who said their exposure at the facility to toxic chemicals made by the company’s Monsanto unit caused brain damage and other injuries.
Corporate conductAllegationAgainst
Bayer is accused of downplaying cerivastatin risks
Bayer is accused of downplaying cerivastatin's risk of rhabdomyolysis and misrepresenting its efficacy compared to other statins.
The lawsuit further alleged that Bayer submitted false claims to the Medicare and Medicaid programs and violated the laws of 20 states and the District of Columbia.
In a second lawsuit, Simpson alleged that Bayer knew about, but downplayed, cerivastatin's risks of causing rhabdomyolysis; misrepresented the efficacy of cerivastatin when compared to other statins; and fraudulently persuaded the Defense Logistics Agency to renew certain contracts relating to cerivastatin.
"As alleged in the complaints, Bayer — one of the largest pharmaceutical companies in the world — engaged in a series of unlawful acts, including paying kickbacks to doctors and hospitals, marketing them off-label, and downplaying their safety risks," Philip R. Sellinger, US attorney for the District of New Jersey, said in the statement.
Corporate conductSettlementAgainst
Bayer settles fraud allegations for $40 million
Bayer settles kickback and fraud allegations for $40 million.
Today, the Department of Justice announced that during the course of the Antitrust Division’s ongoing investigation into exclusionary conduct in corn and soybean seed markets, Bayer CropScience LLC has removed potentially anticompetitive provisions from its loyalty program.
The parties also are settling allegations that Bayer knowingly underpaid the Medicaid program for rebates owed by it to the states.
Workplace equityAllegationAgainst
Six Bayer employees file $100 million gender-discrimination lawsuit
Six former and current employees of Bayer's health-care arm filed a $100 million gender-discrimination lawsuit, claiming the U.S. unit discriminates against female employees in pay, promotion, and pregnancy leave.
Six former and current employees of Bayer…health-care arm filed a $100 million gender-discrimination lawsuit Monday, claiming the U.S. unit discriminates against its female employees in terms of pay and promotion, as well as pregnancy leave.
Lawsuit Claims Discrimination by Bayer [USA] - Business and Human Rights Centre
Corporate conductConfirmedAgainst
Bayer faces 50% fine hike for cartel violations
Bayer receives a 50% increase in fines by the Commission for cartel activities previously fined.